HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The potential role for lixivaptan in heart failure and in hyponatremia.

AbstractINTRODUCTION:
Hypervolemia and hyponatremia are common features in heart failure and have been associated with increased morbidity and mortality. Stimulation of arginine vasopressin (AVP) plays an important role in the development of both hypervolemia and hyponatremia. Lixivaptan is a selective vasopressin type 2 (V(2)) receptor antagonist that has been demonstrated to have the ability to induce aquaresis, the electrolyte sparing excretion of water, resulting in fluid removal as well as correction of hyponatremia.
AREAS COVERED:
This article describes the prevalence, pathophysiology and current treatment limitations of hyponatremia, highlights the importance of arginine vasopressin and the potential role of arginine vasopressin antagonists and reviews all available literature on lixivaptan, a selective V(2) receptor antagonist.
EXPERT OPINION:
The available experience of lixivaptan in heart failure, although limited, is encouraging. Its aquaretic effect provides the basis for its use to correct hypervolemia and hyponatremia in patients with heart failure, and the absence of neurhormonal stimulation provides positive signal for the exploration of its potential in improving outcomes.
AuthorsHammam D Zmily, Nazia S Khan, Suleiman Daifallah, Jalal K Ghali
JournalExpert opinion on investigational drugs (Expert Opin Investig Drugs) Vol. 20 Issue 6 Pg. 831-48 (Jun 2011) ISSN: 1744-7658 [Electronic] England
PMID21548825 (Publication Type: Journal Article, Review)
Chemical References
  • Antidiuretic Hormone Receptor Antagonists
  • Benzamides
  • Pyrroles
  • Arginine Vasopressin
  • lixivaptan
Topics
  • Animals
  • Antidiuretic Hormone Receptor Antagonists
  • Arginine Vasopressin (metabolism)
  • Benzamides (adverse effects, pharmacokinetics, pharmacology)
  • Heart Failure (drug therapy, physiopathology)
  • Humans
  • Hyponatremia (drug therapy, etiology)
  • Plasma Volume (drug effects)
  • Pyrroles (adverse effects, pharmacokinetics, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: